June 24, 2016 — More than 1 in 3 atrial fibrillation (AF) patients at intermediate to high risk for stroke are treated ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
June 24, 2016
June 2, 2016 — Female atrial fibrillation patients are less likely than their male counterparts to receive blood ...
June 02, 2016
May 25, 2016 — Technavio’s latest report on the U.S. anticoagulants market provides an analysis on the most important ...
May 25, 2016
Feature | Left Atrial Appendage (LAA) Occluders | Dave Fornell
Atrial fibrillation (AF) affects nearly 6 million Americans and the condition puts them at significantly greater risk of ...
May 20, 2016May 19, 2016 — Physician-researchers in the College of Medicine at the University of Cincinnati have developed a ...
May 19, 2016
Feature | Antiplatelet and Anticoagulation Therapies | Marianne Pop, Pharm.D., BCPS
There were many opinions on the duration of dual antiplatelet therapy (DAPT) highlighted at the 2016 American College of ...
May 19, 2016
May 16, 2016 — The largest observational study of percutaneous transfemoral transcatheter aortic valve replacement (TAVR ...
May 16, 2016
May 16, 2016 – Women younger than 55 years of age who undergo percutaneous coronary intervention (PCI) for acute ...
May 16, 2016May 16, 2016 — A study on the impact of using different anticoagulation medications on men and women who have undergone ...
May 16, 2016
May 9, 2016 — A new study shows the use of novel anticoagulants to treat atrial fibrillation (AF) on an “as needed basis ...
May 09, 2016
May 9, 2016 — A new study has found an increased risk of dementia in patients with atrial fibrillation (AF) that receive ...
May 09, 2016
May 6, 2016 — Atrial fibrillation patients taking warfarin are at higher risk of developing kidney failure if ...
May 06, 2016
May 6, 2016 — The largest risk-directed study by a national hospital system demonstrates a 40 percent decline in ...
May 06, 2016
April 20, 2016 — Lowering cholesterol with statins significantly reduced adverse cardiovascular events in people with ...
April 20, 2016April 19, 2016 — In one of the largest trials ever conducted of heart failure patients with reduced ejection fraction ...
April 19, 2016© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now